Francesca Blasco

2.1k total citations
20 papers, 897 citations indexed

About

Francesca Blasco is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Francesca Blasco has authored 20 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Organic Chemistry. Recurrent topics in Francesca Blasco's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Computational Drug Discovery Methods (3 papers) and Mosquito-borne diseases and control (3 papers). Francesca Blasco is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Computational Drug Discovery Methods (3 papers) and Mosquito-borne diseases and control (3 papers). Francesca Blasco collaborates with scholars based in Switzerland, Singapore and United States. Francesca Blasco's co-authors include Reiner Aichholz, Pascal Furet, Giorgio Caravatti, Mark Knapp, Patricia Imbach‐Weese, Christine Fritsch, Robin A. Fairhurst, Joachim Blanz, Vito Guagnano and Ian C. Bruce and has published in prestigious journals such as PLoS ONE, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Francesca Blasco

20 papers receiving 882 citations

Peers

Countries citing papers authored by Francesca Blasco

Since Specialization

Citations

This map shows the geographic impact of Francesca Blasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Blasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Blasco more than expected).

Fields of papers citing papers by Francesca Blasco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Blasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Blasco. The network helps show where Francesca Blasco may publish in the future.

Co-authorship network of co-authors of Francesca Blasco

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Blasco. A scholar is included among the top collaborators of Francesca Blasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Blasco. Francesca Blasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format 2016 ·European Journal of Pharmaceutical Sciences ·(unknown), Francesca Blasco, (unknown)	26
2	Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Robin A. Fairhurst, Giorgio Caravatti, Vito Guagnano, Reiner Aichholz, Joachim Blanz, Francesca Blasco, (unknown), Christine Fritsch, Sauveur-Michel Maira, Christian Schnell, (unknown)	1
3	Artificial Neural Network Analysis of Pharmacokinetic and Toxicity Properties of Lead Molecules for Dengue Fever, Tuberculosis and Malaria 2016 ·Current Computer - Aided Drug Design ·Shahul Nilar, Suresh B. Lakshminarayana, (unknown), Thomas H. Keller, Francesca Blasco, Paul J. Smith	1
4	Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Robin A. Fairhurst, Marc Gerspacher, Patricia Imbach‐Weese, Robert Mah, Giorgio Caravatti, Pascal Furet, Christine Fritsch, Christian Schnell, Joachim Blanz, Francesca Blasco, Sandrine Desrayaud, Daniel Guthy, Mark Knapp, (unknown), (unknown), (unknown), (unknown)	15
5	Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580 2014 ·Antiviral Research ·(unknown), Andy M. Yip, Peck Gee Seah, Francesca Blasco, Pei‐Yong Shi, Maxime Hervé	31
6	Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research 2014 ·Frontiers in Pharmacology ·Tove Tuntland, Brian Ethell, Takatoshi Kosaka, Francesca Blasco, Richard Zang, Monish Jain, Ty Gould, Keith Hoffmaster	152
7	Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis 2014 ·PLoS ONE ·Suresh B. Lakshminarayana, Helena I. Boshoff, Joseph Cherian, Sindhu Ravindran, Anne Goh, Jan Jiřiček, Mahesh Nanjundappa, Amit Nayyar, Meera Gurumurthy, Ramandeep Singh, Thomas Dick, Francesca Blasco, Clifton E. Barry, Paul C. Ho, Ujjini H. Manjunatha	21
8	Pharmacokinetic-Pharmacodynamic Analysis of Spiroindolone Analogs and KAE609 in a Murine Malaria Model 2014 ·Antimicrobial Agents and Chemotherapy ·Suresh B. Lakshminarayana, Céline Freymond, Christoph Fischli, Jing Yu, Sebastian Weber, Anne Goh, Bryan K. S. Yeung, Paul C. Ho, Véronique Dartois, Thierry T. Diagana, Matthias Rottmann, Francesca Blasco	12
9	Development of a FACS-based assay for evaluating antiviral potency of compound in dengue infected peripheral blood mononuclear cells 2013 ·Journal of Virological Methods ·(unknown), Yen‐Liang Chen, Maxime Hervé, Feng Gu, Pei‐Yong Shi, Francesca Blasco	6
10	The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588 2013 ·Bioorganic & Medicinal Chemistry ·Paul W. Manley, Francesca Blasco, Jürgen Mestan, Reiner Aichholz	40
11	Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation 2013 ·Bioorganic & Medicinal Chemistry Letters ·Pascal Furet, Vito Guagnano, Robin A. Fairhurst, Patricia Imbach‐Weese, Ian C. Bruce, Mark Knapp, Christine Fritsch, Francesca Blasco, Joachim Blanz, Reiner Aichholz, Jacques Hamon, Doriano Fabbro, Giorgio Caravatti	350
12	Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir 2013 ·Journal of Virology ·Yen‐Liang Chen, (unknown), Ratna Karuna, (unknown), Siew Pheng Lim, Wouter Schul, Feng Gu, Maxime Hervé, (unknown), Gang Wang, Daniela Cerny, Katja Fink, Francesca Blasco, Pei‐Yong Shi	64
13	2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Marc Gerspacher, Pascal Furet, Carole Pissot‐Soldermann, Christoph Gaul, Philipp Holzer, Eric Vangrevelinghe, Marc Lang, Dirk Erdmann, Thomas Radimerski, Catherine H. Régnier, Patrick Chêne, Alain De Pover, Francesco Hofmann, Fabienne Baffert, Thomas Buhl, Reiner Aichholz, Francesca Blasco, (unknown), Jörg Trappe, Peter Drueckes	21
14	Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Carole Pissot‐Soldermann, Marc Gerspacher, Pascal Furet, Christoph Gaul, Philipp Holzer, Clive McCarthy, Thomas Radimerski, Catherine H. Régnier, Fabienne Baffert, Peter Drueckes, Gisele Tavares, Eric Vangrevelinghe, Francesca Blasco, Giorgio Ottaviani, (unknown), (unknown), (unknown)	33
15	Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit 2009 ·European Journal of Medicinal Chemistry ·Katrin Groebke Zbinden, Lilli Anselm, David W. Banner, Jörg Benz, Francesca Blasco, (unknown), Jacques Himber, Bernd Kuhn, Narendra Panday, (unknown)	31
16	Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABAA α5 inverse agonist series 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Theresa M. Ballard, Francesca Blasco, Pierre‐Emmanuel Broutin, Bernd Büttelmann, Holger Fischer, Martin Graf, Maria‐Clemencia Hernandez, (unknown), Frédéric Knoflach, (unknown), Henner Knust, (unknown), James R. Martin, Raffaello Masciadri, Richard H. Porter, Heinz Stadler, Andrew W. Thomas, Gerhard Trube, Jürgen Wichmann	23
17	Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Optimising brain penetration 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jens‐Uwe Peters, Thomas Lübbers, Alexander Alanine, Sabine Kolczewski, Francesca Blasco, Lucinda J. Steward	20
18	Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Structure–activity relationship elucidation 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jens‐Uwe Peters, Thomas Lübbers, Alexander Alanine, Sabine Kolczewski, Francesca Blasco, Lucinda J. Steward	9
19	Trifluoromethyl vs. methyl ability to direct enantioselection in microbial reduction of carbonyl substrates. 1998 ·Tetrahedron ·Alberto Arnone, R. BERNARDI, Francesca Blasco, Rosanna Cardillo, Giuseppe Resnati, Igor I. Gerus, Valery P. Kukhar	35
20	Complete diastereocontrol in [3+2] cycloaddition reactions: Synthesis of enantiomerically pure fluoromethyl substituted β-amino acids 1997 ·Tetrahedron ·Alberto Arnone, Francesca Blasco, Giuseppe Resnati	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact